NQO1 and ovarian carcinoma: Thus, this study clearly showed that overexpression of p62 in cisplatin-resistant ovarian cancer cell line protects cells from oxidative damage caused by vitamin K3 activating NRF2 signaling, then increasing NQO1 expression [79].